Thorough investigation of the effects on physiological macrophage functions caused by biased GPR84 signaling represents a future challenge that must be overcome to draw a general conclusion about the potential of GPR84 agonists for the development of novel therapeutic strategies in CRC. The gene discussed is GPR84; the disease is colorectal carcinoma.